跳至主要内容
临床试验/NL-OMON50767
NL-OMON50767招募中3 期

ewborns with Congenital Diaphragmatic hernia: inhaled Nitric Oxide versus intravenous Sildenafil: ;an international randomized controlled trial - CoDiNOS trial

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 45 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 至 11(—)

入选标准

  • Diagnosis of CDH and pulmonary hypertension defined as 2 of the following 4
  • criteria: , I. PAP> 2/3 systemic pressure estimated by echocardiography ,
  • II. RV dilatation/septal displacement, RV dysfunction +/- LV dysfunction , III.
  • Pre-post ductal SpO2 difference > 10% , IV. OI>20. , • Parental informed
  • consent, • Children born at or after a gestational age of 34 weeks , • Newborns
  • who received a fetal intervention may be included

排除标准

  • Severe chromosomal anomaly, like trisomy 18 or trisomy 13, which may imply a
  • decision to stop or not to start life-saving medical treatment, • Severe
  • cardiac anomaly, expected to need corrective surgery in the first 60 days of
  • life (such as transposition of the great arteries, truncus arteriosus,
  • coarctation aortae or double outlet right ventricle), • Renal anomalies
  • associated with oligohydramnios, • Severe orthopaedic and skeletal deformities,
  • which are likely to influence thoracic, and / or lung development (such as
  • chest wall deformities and spine anomalies), • Severe anomalies of the central
  • nervous system, • iNO already started for postnatal transport

研究者

相似试验

ewborns with Congenital Diaphragmatic hernia:... | 临床试验